Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | FT522 |
Trade Name | |
Synonyms | FT-522|FT 522 |
Drug Descriptions |
Limited information is currently available on FT522, a putative iPSC-derived CAR-NK cell based immunotherapy (Nov 2023). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bendamustine + FT522 + Rituximab | Bendamustine FT522 Rituximab | 0 | 1 |
Cyclophosphamide + Fludarabine + FT522 + Rituximab | Cyclophosphamide FT522 Fludarabine Rituximab | 0 | 1 |
FT522 | FT522 | 0 | 0 |
FT522 + Rituximab | FT522 Rituximab | 0 | 1 |